Clinical Trials Logo

Filter by:
NCT ID: NCT05519124 Completed - Wrinkle Clinical Trials

BTL-785F Device for Non-invasive Reduction of Wrinkles

Start date: November 3, 2021
Phase: N/A
Study type: Interventional

This study will evaluate the clinical safety and the performance of the BTL-785F system equipped with the BTL-785-7 applicator for non-invasive treatment of facial wrinkles. The study is a multicenter single-arm, open-label, interventional study.

NCT ID: NCT05518981 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Effect of Remote Physiologic Monitoring (RPM) on Outcomes in COPD Patients

Start date: May 1, 2019
Phase:
Study type: Observational

This pre/post study was a retrospective analysis of unplanned hospitalization rates in a cohort of COPD subjects started on remote physiologic monitoring (RPM) at a large, outpatient pulmonary practice. The study included all subjects with high healthcare utilization (≥1 hospitalization or emergency room visit in the prior year) who had elected to enroll in an RPM service for assistance with clinical management. Additional inclusion criteria included being on RPM for at least 12 months and a patient of the practice for at least two years (12 months pre- and post-initiation of RPM).

NCT ID: NCT05518734 Completed - Pain Clinical Trials

A Phase 1 Dose Escalation Study of VX-708 in Healthy Participants

Start date: September 17, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, pharmacokinetics, and pharmacodynamics of multiple ascending doses of VX-708 in healthy participants

NCT ID: NCT05518461 Completed - COVID-19 Clinical Trials

Smartphone Intervention for Overdose and COVID-19

Start date: December 19, 2022
Phase: N/A
Study type: Interventional

This study will examine if the use of a smartphone application called Thrive4Life Connect can help people who use drugs lower their risk of overdose and learn more about COVID-19 vaccines. 60 participants will be enrolled and can expect to be on study for up to 6 months.

NCT ID: NCT05518019 Completed - Anxiety Clinical Trials

An Exploratory Investigation of a CBD Supplement's Impact on Sleep, Stress, and Focus

Start date: February 14, 2022
Phase: N/A
Study type: Interventional

A high-quality broad-spectrum cannabidiol supplement with a bio-terpene complex will be administered once daily. It is hypothesized that this supplement will lead to improvements in sleep, focus, and stress. Previous research supports that CBD supplementation provides support to the endocannabinoid system, allowing the brain to better control negative psychological outcomes like fear, stress, and negative mood states.

NCT ID: NCT05517720 Completed - Acne Clinical Trials

An Exploratory Investigation of a Novel Skincare Regimen

Start date: April 13, 2022
Phase: N/A
Study type: Interventional

This trial will assess the effectiveness of the Aria Trio Complete Facial system in being able to reduce blemishes, lines, and wrinkles. This skincare system that has three different functions in association with three unique serums. It is hypothesized that this customized skincare system will improve skin quality, reduce wrinkles, and reduce other skin related issues.

NCT ID: NCT05517707 Completed - Nasogastric Tube Clinical Trials

Gravitas Feeding Tube System Placement in Neonates

Start date: November 10, 2022
Phase:
Study type: Observational

The purpose of this study is to optimize the Gravitas Feeding Tube System Placement Algorithm for NICU patients and to evaluate the safety and effectiveness of the Gravitas Feeding Tube in the neonate population for the administration of nutrition, fluids and medications.

NCT ID: NCT05517525 Completed - Hepatic Impairment Clinical Trials

A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Brensocatib in Participants With Normal Hepatic Function and Participants With Hepatic Impairment

Start date: October 4, 2022
Phase: Phase 1
Study type: Interventional

The primary purpose of the study is to compare the PK of a single dose of brensocatib in participants with hepatic impairment to that in matched healthy control participants with normal hepatic function.

NCT ID: NCT05517382 Completed - Suicide Clinical Trials

A Digital Game Targeting Suicide Prevention in Adolescents Who Report Substance Misuse

Start date: December 21, 2022
Phase: N/A
Study type: Interventional

The primary aim of this study is to design and develop a digital game that models the process of a safety planning intervention. To do so, the investigators will explore and better understand peer or student perceptions around potential warning signs, coping strategies, and seeking help among youth who may be at greater risk of suicide due to misuse of substances. Focus groups/interviews with adolescents, young adults, adults, and school-based behavioral health providers will be conducted. Findings will inform the development of a digital intervention to reduce the risk of suicide among adolescents who misuse substances. Once a prototype of the game is developed, play-test focus groups with adolescents, college-aged youth, and school-based mental health providers will be conducted to finalize the intervention. Once finalized, the investigators will conduct a pilot study with 60 adolescents aged 13-19 to assess user experience, acceptability and feasibility of the digital game.

NCT ID: NCT05517161 Completed - Clinical trials for Communication Disorder, Social

Roll for Intervention - TBI Group Treatment

Start date: May 2, 2022
Phase:
Study type: Observational

Communication group intervention for individuals with Traumatic Brain Injury based on INSIGHT protocol (Keegan et al, 2020) with roll playing game focus